Today, diagnosis and treatment are increasingly integrated. This reflects developments in several key areas: scientific, diagnosis, evidence-based therapies, advancing personalized care and improved process efficiency. The need to improve patient diagnosis is today driving healthcare providers to improve management and process efficiency.
The rapidly evolving IV2D field offers important opportunities to diagnostic imaging companies. While imaging continues to see important refinements, the development of new imaging systems is challenging. In contrast, substantial numbers of in-vivo biomarkers are being discovered, offering combined "hybrid" integrations with imaging.
Siemens is a global provider of medical diagnostic systems, incorporating primary tests and instrumentation, IT platforms and software solutions, for clinical data handling and processing. Siemens is also developing technologies in the field of integrated diagnostics.
Key reasons to purchase this research
• What are the major imaging systems in diagnosis and how are they being applied to diagnosis in breast cancer and Alzheimer's disease?
• What are the business models of some of the major diagnostic companies as they establish new integrated diagnostic and healthcare capabilities?
• What levels of support and capability do healthcare providers seek from companies offering products and services in the fields of diagnostics?
• What strategies are the major diagnostic companies taking to reduce costs of the healthcare products and services?
• Why is it anticipated that the next decade will see substantial growth in the integrated diagnostics field?
Table of Contents
About the author 2
Executive summary 9
The diagnostic-centric healthcare delivery model 9
IV2D Enabling Technologies 10
IV2D Initiatives at Academic Medical Cen
Copyright©2010 PR Newswire.
All rights reserved